Matrix Gla protein reinforces angiogenic resolution.

Area of Science:

• Vascular Biology
• Molecular Biology
• Developmental Biology

Background:

• Matrix Gla Protein (MGP) is an extracellular matrix protein implicated in large blood vessel diseases.
• The specific role of MGP in microvascular development and function remains largely undefined.

Purpose of the Study:

• To investigate the function of MGP in angiogenesis, focusing on its role in microvasculature, and its potential interaction with signaling pathways.
• To determine if MGP acts as an inhibitor of normal and pathological angiogenesis.

Main Methods:

• Utilized a mouse MGP knockout model to assess MGP's impact on angiogenic sprouting and microvascular density.
• Employed morpholino-based knockdown in zebrafish embryos to observe effects on vascular development.
• Analyzed MGP's influence on Notch and BMP signaling pathways in aortic ring assays.

Main Results:

• MGP knockout mice exhibited suppressed angiogenic sprouting from aorta and reduced microvascular density in cardiac and skeletal muscle.
• MGP acts as an endogenous inhibitor of tumor angiogenesis.
• Zebrafish MGP knockdown resulted in impaired intersegmental vessel development, similar to Dll4/Notch inhibition.
• MGP suppressed Notch-dependent Hes-1 promoter activity and modulated Jagged1/Dll4 mRNA ratios.
• Inhibition of BMP signaling, but not Notch or VEGF, reversed excessive angiogenic sprouting in MGP knockout aortic rings.

Conclusions:

• Matrix Gla Protein (MGP) is a multi-functional inhibitor of normal and abnormal angiogenesis.
• MGP appears to suppress angiogenic sprouting by antagonizing BMP signaling.
• MGP may coordinate its inhibitory functions through interactions with both Notch and BMP signaling pathways.